BioLineRx Ltd. Issued Capital
BioLineRx Ltd. (BLRX) had Issued Capital of $73.43 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IssuedCapital · last filed 2026-03-23
- 2025-12-31: Issued Capital $73.43M.
- 2025-06-30: Issued Capital $71.82M.
- 2024-12-31: Issued Capital $38.10M.
- 2024-06-30: Issued Capital $34.41M.
| Period end | Issued Capital |
|---|---|
| 2025-12-31 | $73.43M 20-F · filed 2026-03-23 |
| 2025-06-30 | $71.82M 6-K · filed 2025-08-14 |
| 2024-12-31 | $38.10M 20-F · filed 2026-03-23 |
| 2024-06-30 | $34.41M 6-K · filed 2024-08-15 |
| 2023-12-31 | $31.36M 20-F · filed 2025-03-31 |
| 2023-06-30 | $27.10M 6-K · filed 2023-08-30 |
| 2022-12-31 | $27.10M 20-F · filed 2024-03-26 |
| 2022-06-30 | $21.16M 6-K · filed 2022-08-16 |
| 2021-12-31 | $21.07M 20-F · filed 2023-03-22 |
| 2021-06-30 | $20.50M 6-K · filed 2021-08-18 |
| 2020-12-31 | $9.87M 20-F · filed 2022-03-16 |
| 2020-06-30 | $8.28M 6-K · filed 2020-08-06 |
| 2019-12-31 | $4.69M 20-F · filed 2021-02-23 |
| 2019-06-30 | $4.00M 6-K · filed 2019-08-06 |
| 2018-12-31 | $3.11M 20-F · filed 2020-03-12 |
| 2018-06-30 | $2.92M 6-K · filed 2018-08-13 |
| 2017-12-31 | $2.84M 20-F · filed 2019-03-28 |
| 2016-12-31 | $1.51M 20-F · filed 2018-03-06 |